Makrakis D, Talukder R, LIN GI, Diamantopoulos LN, Dawsey S, Gupta S, Carril-Ajuria L, Castellano D, DE Kouchkovsk, Koshkin VS, Park JJ, Alva A, Bilen MA, Stewart TF, McKay RR, Tripathi N, Agarwal N, Vather-Wu N, Zakharia Y, Morales-Barrera R, Devitt ME, Cortellini A, Fulgenzi CAM, Pinato DJ, Nelson A, Hoimes CJ, Gupta K, Gartrell BA, Sankin A, Tripathi A, Zakopoulou R, Bamias A, Murgic J, Fröbe A, Rodríguez-Vida A, Drakaki A, Liu S, Lu E, Kumar V, di Lorenzo G, Joshi M, Isaacsson-Velho P, Buznego L, Duran I, Moses M, Jang A, Barata P, Sonpavde G, Yu EY, Montgomery RB, Grivas P
*, Khaki AR
*.
Association Between Sites of Metastasis and Outcomes With Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma. Clin Genitourin Cancer 2022: (en Premsa).